Tradecurve, SOL, COMP Aim to be promising crypto assets in August

Tradecurve (TCRV) Seems Set to Moon Whilst dYdX (DYDX) and Other DeFi Tokens Decline

Three of the most promising altcoins on the horizon are Tradecurve (TCRV), Solana (SOL), and Compound (COMP). Three altcoins are positioned to see gains in the coming month. Of these, Tradecurve (TCRV) holds the most promise. It continues to gain traction in a presale event of discounted tokens.

Solana (SOL): Empowering DeFi and NFTs with Blazing Fast Transactions

The next altcoin to watch out for is Solana (SOL), a high-performance blockchain platform that delivers a blisteringly fast transaction throughput of up to 65K per second.

Solana is one of this week’s biggest gainers, with a weekly gain of over 22%. Solana tokens were previously sold by concerned Solana holders worried about the implications of the SEC clamping down on the altcoin market.

A closer look at Solana’s chart reveals that it has just successfully broken out of a descending triangle pattern that had been suppressing its price for over a year. The next crucial resistance level Solana traders are keen on is $30.

Breaking this $30 level could spur an even larger Solana price surge toward the $80 mark, a key support/resistance level for the past few years.


Compound (COMP): Revolutionizing Lending and Borrowing in DeFi

The decentralized finance (DeFi) sector has witnessed a growing interest. Compound (COMP) is emerging as one of the top projects. Compound enables users to deposit their cryptocurrencies into various liquidity pools. Thereby it earns interest on their deposits for the length of time that they remain in the pool.

Compound is demonstrating remarkable growth. This is with its price surging from $52 to over $80 over the course of just seven days. A key factor contributing to this bullish momentum is Compound’s breakout from a Descending Triangle pattern. It is a technical indicator that frequently signals the start of a strong bullish trend.

The Compound price now rests at $73 after a small price correction. $100 is the next resistance level for Compound. These analysts are confident that it will test in the near future. A breach of this level would kick start a fresh bull run for Compound and perhaps an all-time high.

Tradecurve (TCRV): Unveiling the Next-Gen Decentralized Exchange

Tradecurve stands out in the exchange space with its hybrid design. It ingeniously merges the advantages of both centralized and decentralized exchanges. This unique model provides a highly secure trading environment while offering high liquidity, low latency, and minimal trading fees.

In addition to crypto, Tradecurve expands its trading options. It includes a broad array of financial assets, such as forex, commodities, and stocks. Users sign up with an email address. They deposit crypto to use as collateral and get instant access to trade and margin leverage.

Tradecurve raises the bar further by introducing KYC-free trading so that users can trade without the need to provide any personal data. It ensures their anonymity and security without compromising on platform functionality.

Tradecurve is currently in its fifth presale phase, with its native token, TCRV, available at just $0.025 per token. The response has been phenomenal, with phase 4 selling out in record time. The next presale phase will see the token price rise to $0.029, so early buyers will profit before the token even launches.

Tradecurve’s unique blend of hybrid exchange functionality, diverse asset availability, and anonymity stands to disrupt the traditional exchange landscape. Analysts predict that once TCRV hits the public exchanges, its price could reach the $1.00 mark, making now the ideal time to invest.

For more information about the Tradecurve (TCRV) presale:


Buy presale: 



Disclaimer: This is a sponsored article, and views in it do not represent those of, nor should they be attributed to, ZyCrypto. Readers should conduct independent research before taking any actions related to the company, product, or crypto projects mentioned in this piece; nor can this article be regarded as investment advice.